2023年某三甲医院门急诊第二类精神药品使用情况分析与措施  

Analysis and Measures of the Use of Class II Psychotropic Drugs in the Outpatient and Emergency Department of A Third Class Hospital in 2023

作　　者：李凡 唐莉华 黄学娣 陈青峰 张常维 LI Fan;TANG Lihua;HUANG Xuedi;CHEN Qingfeng;ZHANG Changwei(Jiangxi Province Integrated Traditional Chinese and Western Medicine Hospital,Nanchang Jiangxi 330003,China;Nanchang Hongdu Traditional Chinese Medicine Hospital,Nanchang Jiangxi 330013,China)

机构地区：[1]江西省中西医结合医院,江西南昌330003 [2]南昌市洪都中医院,江西南昌330013

出　　处：《药品评价》2024年第4期397-401,共5页Drug Evaluation

摘　　要：目的该研究旨在分析2023年某三甲医院门急诊第二类精神药品的使用情况。方法通过对2023年某三甲医院门急诊11657张处方的数据进行分析,包括年龄、科室分布、用药频度(DDDs)、日均费用(DDDc)、药品排序比(B/A)、药物利用指数(DUI)等指标。结果60岁以上患者的处方量占比最高;神经内科、心血管内科等科室使用最多;右佐匹克隆片(3 mg)和艾司唑仑片(1 mg)的使用频度最高,分别为44.20%和40.11%;阿普唑仑片DDDc最低,地佐辛泮注射液DDDc最高;阿普唑仑片和右佐匹克隆片(3 mg)的B/A值大于1;地佐辛注射液的DUI值1.41,右佐匹克隆片(3 mg)DUI值1.02。结论该院第二类精神药品使用基本合理,但个别药品需加强监管,研究结果可为临床合理用药提供参考,保障患者用药安全。Objective The purpose of this study was to analyze the use of class II psychotropic drugs in the outpatient and emergency department of a third class hospital in 2023.Methods The data of 11657 outpatient and emergency prescriptions in a third class hospital in 2023 were analyzed,including age,department distribution,and daily dose system(DDDs),define daily dose cost(DDDc),B/A ratio(B/A),drug utilization index(DUI)and other indicators.Results Patients over 60 years old had the highest proportion of prescriptions.The department of neurology,cardiovascular medicine and other departments used the most;dexzopiclone tablets(3 mg)and esazolam tablets(1 mg)were the most frequently used tablets,44.20%and 40.11%,respectively.The DDDc of alprazolam tablets was the lowest,and the DDDc of dizopam injection was the highest.The B/A values of alprazolam tablets and dexzopiclone tablets(3 mg)were greater than 1.The DUI value of dezocine injection was 1.41,and that of dexzopiclone tablet(3 mg)was 1.02.Conclusion The use of class II psychotropic drugs in this hospital is basically reasonable,but the supervision of individual drugs needs to be strengthened.The study results can provide reference for rational drug use in clinical practice and ensure the safety of drug use.

关 键 词：第二类精神药品 用药分析 药品排序比 药物利用指数 应对措施 

分 类 号：R95[医药卫生—药学]